Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma

被引:11
作者
Li, Zhen-Li [1 ]
Han, Jun [1 ]
Liu, Kai [1 ]
Xing, Hao [1 ]
Wu, Han [1 ]
Lau, Wan Yee [1 ,2 ]
Pawlik, Timothy M. [3 ]
Li, Chao [1 ]
Wang, Ming-Da [1 ]
Yu, Jiong-Jie [1 ]
Wu, Meng-Chao [1 ]
Shen, Feng [1 ]
Yang, Tian [1 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, 225 Changhai Rd, Shanghai 200438, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Shatin, Hong Kong, Peoples R China
[3] Ohio State Univ, Wexner Med Ctr, Dept Surg, Columbus, OH USA
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma (HCC); hepatitis B; hepatectomy; survival; recurrence; HEPATITIS-B-VIRUS; CURATIVE RESECTION; CANCER RECURRENCE; RISK-FACTORS; SURVIVAL; IMPACT; STATISTICS; CARRIERS;
D O I
10.21037/hbsn.2018.11.20
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Family history is a risk factor for the development of hepatocellular carcinoma (HCC). The aim of the current study was to investigate the association between family history of HCC and long-term oncologic prognosis among patients undergoing curative liver resection for hepatitis B virus (HBV)-related HCC. Methods: Patients who underwent curative liver resection of HBV-related HCC between 2003 and 2013 were consecutively enrolled. Family history was defined as a self-reported history of HCC in a first-degree relative. Propensity score matching (PSM) and multivariable Cox-regression analyses were performed to compare overall survival (OS) and recurrence-free survival (RFS) among patients with and without a family history. Results: Among 1,112 patients, 183 (16.5%) patients had a family history of HCC. Using PSM, 179 pairs of patients with and without a family history were created that had no differences in the baseline characteristics and operative variables. On matched analysis, family history was associated with decreased OS and RFS after curative-intent resection of HBV-related HCC in the propensity matching cohort (P=0.042 and 0.006, respectively). On multivariable Cox-regression analyses, a family history of HCC was associated with decreased OS (HR: 1.574; 95% CI: 1.171-2.116; P=0.003) and RFS (HR: 1.534; 95% CI: 1.176-2.002; P=0.002) after adjusting for other prognostic risk factors. Conclusions: Family history was associated with decreased OS and RFS rates among patients undergoing curative liver resection of HBV-related HCC.
引用
收藏
页码:88 / 100
页数:13
相关论文
共 39 条
[1]  
[Anonymous], 2018, JAMA SURG
[2]   Association of family history with cancer recurrence and survival among patients with stage III colon cancer [J].
Chan, Jennifer A. ;
Meyerhardt, Jeffrey A. ;
Niedzwiecki, Donna ;
Hollis, Donna ;
Saltz, Leonard B. ;
Mayer, Robert J. ;
Thomas, James ;
Schaefer, Paul ;
Whittom, Renaud ;
Hantel, Alexander ;
Goldberg, Richard M. ;
Warren, Robert S. ;
Bertagnolli, Monica ;
Fuchs, Charles S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (21) :2515-2523
[3]   Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma [J].
Chen, CH ;
Huang, GT ;
Lee, HS ;
Yang, PM ;
Chen, DS ;
Sheu, JC .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 27 (03) :236-239
[4]  
CHEN CJ, 1991, HEPATOLOGY, V13, P398, DOI 10.1002/hep.1840130303
[5]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[6]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[7]  
2-B
[8]   The impact of family history of hepatocellular carcinoma on its patients' survival [J].
Dai, Wing Chiu ;
Fan, Sheung Tat ;
Cheung, Tan To ;
Chok, Kenneth S. H. ;
Chan, Albert C. Y. ;
Tsang, Simon H. Y. ;
Poon, Ronnie T. P. ;
Lo, Chung Mau .
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (02) :160-164
[9]  
Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO
[10]  
2-2